Catalent is a global leader in drug formulation development that offers comprehensive early phase drug development solutions. Specializing in PBPK modeling, molecule characterization, bioavailability enhancement, API-sparing development techniques, and phase-appropriate dose forms, Catalent helps get optimal drug candidates to clinic, faster. Catalent’s integrated solutions, such as OptiForm® Solution Suite, Catalent Xpress Pharmaceutics® and OneXpress® Solution, aid in accelerating molecules from candidate to clinic and beyond. Its capabilities in lipid-based drug delivery systems, spray drying, hot melt extrusion, modified release and particle-size reduction , combined with broad expertise in developing challenging compounds, provide customers with optimal dosage forms to suit the objectives of each program.